Gain Therapeutics, Inc.
GANX
$1.65
-$0.04-2.37%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/8/2026
-
TipRanks
5/28/2026
-
TipRanks Financial Blog
5/27/2026
-
TipRanks Financial Blog
5/27/2026
-
Simply Wall St
5/26/2026
-
Globe Newswire
5/11/2026
-
The Cerbat Gem
5/11/2026
-
MarketBeat
5/11/2026
-
Globe Newswire
5/5/2026
-
The Cerbat Gem
5/5/2026
-
MarketBeat
4/24/2026
-
Globe Newswire
4/17/2026
-
TipRanks Financial Blog
4/12/2026
-
MarketBeat
4/1/2026
-
MarketBeat
3/26/2026
-
MarketBeat
3/26/2026
-
TipRanks Financial Blog
3/26/2026
-
Globe Newswire
Gain Therapeutics Highlights GT-02287 Biomarker Signals, Eyes Phase 2 Start in Q3 at Roth Conference
3/24/2026
-
MarketBeat
3/21/2026
-
TipRanks Financial Blog
3/21/2026
-
TipRanks Financial Blog
3/19/2026
-
Globe Newswire
3/19/2026
-
MarketBeat
3/19/2026
-
Ticker Report
3/18/2026
-
Market News Video
3/18/2026
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 26, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
301 500 1556
Address
4800 Montgomery Lane
Bethesda, MD 20814
Bethesda, MD 20814
Country
Year Founded
Business Description
Sector
Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and...
more